Therapeutic options for autonomic symptoms and anovulation in premature ovarian insufficiency
E. N. Andreeva, Yu. S. Absatarova · 2019 · Russian Bulletin of Obstetrician-Gynecologist. 19(5):61–67. Issue year 2019; publisher web date 2020.
Study findings
Corpora lutea were observed in 13 women receiving Pineamin with estrogen/progestogen, one receiving hormone therapy alone, and none receiving Pineamin alone. The abstract reports no significant between-group differences in LH, FSH or AMH, despite within-group hormonal changes.
- Population and setting
- 66 women, three groups of 22
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Allocation and blinding are not established by the abstract. Baseline kisspeptin differed between groups.
- Ultrasound findings do not establish live-birth benefit or reversal of ovarian aging.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Publisher abstract checked; full methods and supplementary data not appraised.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: E. N. Andreeva, Yu. S. Absatarova. Therapeutic options for autonomic symptoms and anovulation in premature ovarian insufficiency Russian Bulletin of Obstetrician-Gynecologist. 19(5):61–67. Issue year 2019; publisher web date 2020. 2019.
Molekul research summary: https://molekul.io/research/pineamin-ovarian-2019. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry